Daniel Park
Keine laufenden Positionen mehr
Profil
Daniel S.
Park served as the Executive Vice President at ILJIN Holdings Co., Ltd.
and as the Non-Executive Director & Chief Business Officer at Isotechnika Pharma, Inc. in 2012.
He also served as an Independent Director at Aurinia Pharmaceuticals, Inc. Mr. Park holds an MBA from the University of California, Los Angeles and completed his undergraduate and graduate studies at Seoul National University.
Ehemalige bekannte Positionen von Daniel Park
Unternehmen | Position | Ende |
---|---|---|
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Direktor/Vorstandsmitglied | 28.06.2012 |
AURINIA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | - |
ILJIN HOLDINGS CO.,LTD. | Corporate Officer/Principal | - |
Ausbildung von Daniel Park
University of California, Los Angeles | Masters Business Admin |
Seoul National University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ILJIN HOLDINGS CO.,LTD. | Producer Manufacturing |
AURINIA PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |